CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,048,173,000 | +717826.7% | 155,285 | +578.5% | 0.02% | +750.0% |
| Q1 2020 | $146,000 | -91.0% | 22,885 | -35.6% | 0.00% | -75.0% |
| Q2 2018 | $1,615,000 | -63.7% | 35,524 | -45.7% | 0.01% | -68.0% |
| Q4 2017 | $4,445,000 | +51.1% | 65,371 | +83.1% | 0.02% | +25.0% |
| Q3 2017 | $2,942,000 | -53.9% | 35,699 | -47.6% | 0.02% | -61.5% |
| Q2 2017 | $6,382,000 | +21.7% | 68,158 | -17.2% | 0.05% | +18.2% |
| Q1 2017 | $5,243,000 | +59.5% | 82,333 | +40.2% | 0.04% | +12.8% |
| Q4 2014 | $3,288,000 | +6.4% | 58,712 | -21.3% | 0.04% | +18.2% |
| Q2 2014 | $3,091,000 | +973.3% | 74,635 | +1696.7% | 0.03% | +725.0% |
| Q1 2014 | $288,000 | – | 4,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |